Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT03475940 |
| Other study ID # |
Si2018-2 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
December 31, 2017 |
| Est. completion date |
June 30, 2020 |
Study information
| Verified date |
November 2020 |
| Source |
Mahidol University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Coagulopathy in cardiac surgery; a quaternary-care academic center experience
Objectives:
Primary:
To determine incidence of coagulopathy after cardiac surgery in Thai people To determine
incidence of resternotomy for stop bleeding, morbidity and mortality
Secondary:
To identify risk factors which associated with non-red cell transfusion and coagulopathy
study decide: Retrospective chart review
Description:
Data to be collected:
Age*, gender* Body weight, height, body mass index* Underlying disease: DM, renal disease*,
liver disease* Pre-op. Antiplatelet or anticoagulant* Pre-op coagulogram and platelet count*
Emergency or elective surgery Resternotomy or not* Intraoperative blood component
Intraoperative factor concentration Dose and timing of antifibrinolytic administration* CPB
time* Postoperative body temperature*
*Possible risk factors for non-red cell transfusion
statistic: To assess the relationship between risk factors and non-red cell transfusion a
univariate analysis was performed using an unpaired t-test and a Chi-square test.
For higher accuracy regarding the impact of single risk factors, a multiple logistic
regression analysis was also performed.
